Brief: Pharmena Files For Patent For 1-MNA Use For Use In Viral Infections And Allergies
April 8 (Reuters) - Pharmena SA PHR.WA :
* FILES FOR PATENT FOR 1-MNA USE FOR USE IN VIRAL INFECTIONS
AND
ALLERGIES
* INFECTIONS INCLUDE IN PARTICULAR THOSE RESULTING IN AIRWAY
INFLAMMATION, INCLUDING SARS-COV-2, PNEUMONIA, BRONCHITIS,
ASTHMA
Source text for Eikon: ID:nEM9dlmx9a
Further company coverage: PHR.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Pharmena SA
See all newsBrief: Pharmena Makes Cession Of Rights And Obligations From Unit Menavitin
Brief: Pharmena Signs Two Distribution Deals For US, Canada And Mexico Markets
Brief: Pharmena 9-Month Net Loss Narrows To 0.7 Mln Zlotys
Brief: Pharmena Plans To Separate Dermocosmetic Business
Brief: Pharmena H1 Net Loss Narrows To 0.6 Mln Zlotys